Contract manufacturing
Generic Formulations
- State-of-the art facilities, which adhere to stringent specifications of cGMP and TGA-Australia, MCC-South Africa approved.
- Production capacity of Tablets 3,900 million / year, Capsules 150 million / year, Liquids 6,000 kilo liters / year, Vials + Ampoules 168 million / year.
- Capabilities to produce dosage forms in sterile and general, covering all therapeutic segments along with lyophilization facility.
- Isolated and dedicated production facilities for Beta-Lactam, Cephalosporin, Rifampicin dosage forms and Insulin.
- Qualified and experienced technical team in the areas of manufacturing, quality control, quality assurance, research and development, for all range of products.
- Experienced professionals and highly qualified management and staff, with SAP ERP and Supply Chain Management in place.